Trial · NCT01965652
Results by group136
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 136
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events | Naldemedine | Adverse events | 425 | participants | |
| Number of Participants With Adverse Events | Placebo | Adverse events | 446 | participants | |
| Number of Participants With Adverse Events | Naldemedine | Adverse drug reactions | 149 | participants | |
| Number of Participants With Adverse Events | Placebo | Adverse drug reactions | 121 | participants | |
| Number of Participants With Adverse Events | Naldemedine | AEs leading to discontinuation of study drug | 39 | participants | |
| Number of Participants With Adverse Events | Placebo | AEs leading to discontinuation of study drug | 36 | participants | |
| Number of Participants With Adverse Events | Naldemedine | Serious adverse events | 60 | participants | |
| Number of Participants With Adverse Events | Placebo | Serious adverse events | 73 | participants | |
| Number of Participants With Adverse Events | Naldemedine | Serious adverse drug reactions | 3 | participants | |
| Number of Participants With Adverse Events | Placebo | Serious adverse drug reactions | 6 | participants | |
| Number of Participants With Adverse Events | Naldemedine | SAEs leading to discontinuation of study drug | 7 | participants | |
| Number of Participants With Adverse Events | Placebo | SAEs leading to discontinuation of study drug | 12 | participants | |
| Number of Participants With Adverse Events | Naldemedine | Deaths | 1 | participants | |
| Number of Participants With Adverse Events | Placebo | Deaths | 3 | participants | |
| Change From Baseline in the Number of Bowel Movements Per Week | Naldemedine | Week 12 | 3.70 | Standard Error 0.163 | bowel movements / week |
| Change From Baseline in the Number of Bowel Movements Per Week | Placebo | Week 12 | 2.42 | Standard Error 0.162 | bowel movements / week |
| Change From Baseline in the Number of Bowel Movements Per Week | Naldemedine | Week 24 | 3.77 | Standard Error 0.172 | bowel movements / week |
| Change From Baseline in the Number of Bowel Movements Per Week | Placebo | Week 24 | 2.77 | Standard Error 0.172 | bowel movements / week |
| Change From Baseline in the Number of Bowel Movements Per Week | Naldemedine | Week 36 | 3.88 | Standard Error 0.180 | bowel movements / week |
| Change From Baseline in the Number of Bowel Movements Per Week | Placebo | Week 36 | 2.88 | Standard Error 0.177 | bowel movements / week |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01965652/results